A novel model for Ki67 assessment in breast cancer.

Research output: Contribution to journalArticlepeer-review

32 Citations (SciVal)
170 Downloads (Pure)


Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting.
Original languageEnglish
Article number118
JournalDiagnostic Pathology
Issue number1
Publication statusPublished - 2014

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Pathology, (Lund) (013030000), Oncology, MV (013035000)

Subject classification (UKÄ)

  • Cancer and Oncology


Dive into the research topics of 'A novel model for Ki67 assessment in breast cancer.'. Together they form a unique fingerprint.

Cite this